Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03195270 · ClinicalTrials.gov registry record · Phase 1
Use of PET/MR Imaging in Chronic Pain
A Phase 1 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 1
- Development phase
- 88
- Enrollment target
NCT03195270: Completed Phase 1 study, sponsored by Stanford University.
NCT03195270 is a Phase 1 study that has completed, run by Stanford University. The registered enrollment target is 88 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (47% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03195270, a Phase 1 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 88 participants
- Enrollment target
Study Summary
The investigators are studying the ability of PET/MR imaging (using the PET tracer \[18F\]FDG) to objectively identify and characterize pain generators in patients suffering from chronic pain.
Primary Outcome
Identification of structures with increased \[18F\]FDG uptake (SUVmax) corresponding to pain.
Interventions
- DEVICE PET/MRI
- DRUG [18F]FDG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2014-11-24 |
| Est. Completion | 2022-01-20 |
| Phase | Phase 1 |
What the finished NCT03195270 record still lists
NCT03195270 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (47% higher).
The record links to 0 conditions, and to 2 interventions - of which PET/MRI is the first listed.
NCT03195270 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03195270 about?
NCT03195270 is a clinical study titled "Use of PET/MR Imaging in Chronic Pain". The investigators are studying the ability of PET/MR imaging (using the PET tracer \[18F\]FDG) to objectively identify and characterize pain generators in patients suffering from chronic pain.
What is the current status of trial NCT03195270?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 88 participants. The study started on 2014-11-24. Estimated completion is 2022-01-20.
What interventions are being tested in trial NCT03195270?
The interventions under investigation include: PET/MRI (DEVICE), [18F]FDG (DRUG).
Who is sponsoring clinical trial NCT03195270?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03195270's enrollment target sits among peer trials
88 650th of 2000 higher than 1,350 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI